IRE or Institut National des Radioéléments is a public utility foundation, whose main activity is the production of radioisotopes for diagnostic and therapeutic applications in the field of nuclear medicine. IRE is the world leader in the production of Molybdenum-99. In addition to its production activities, the IRE contributes to the protection and monitoring of the environment through its services of measuring radioactivity in various samples, radiological characterisation of waste and contaminated elements and consultancy and technical assistance in the radiological and nuclear fields.
IRE ELiT, IRE’s innovation subsidiary, was founded in 2010 to develop radiopharmaceuticals used for imaging and treatment of certain cancers and palliative care.